Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3143841
Max Phase: Preclinical
Molecular Formula: C21H29N4O11PSe
Molecular Weight: 623.41
Molecule Type: Small molecule
Associated Items:
ID: ALA3143841
Max Phase: Preclinical
Molecular Formula: C21H29N4O11PSe
Molecular Weight: 623.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COP(=O)(O[C@H]1C[C@H](n2cc(C)c(=O)[nH]c2=O)O[C@@H]1CO)[Se]C[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1O
Standard InChI: InChI=1S/C21H29N4O11PSe/c1-10-6-24(20(30)22-18(10)28)16-4-12(27)15(35-16)9-38-37(32,33-3)36-13-5-17(34-14(13)8-26)25-7-11(2)19(29)23-21(25)31/h6-7,12-17,26-27H,4-5,8-9H2,1-3H3,(H,22,28,30)(H,23,29,31)/t12-,13-,14+,15+,16+,17+,37?/m0/s1
Standard InChI Key: DWGRBBFYLYOYGX-NYRGVRAPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 623.41 | Molecular Weight (Monoisotopic): 624.0736 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wozniak LA, Sochacki M, Mitsuya H, Kageyama S, Stec WJ. (1994) A new class of dinucleotide analogues. The synthesis of 3-O-thymidylyl(5-deoxy-5-selene-thymidylyl)-Se-phosphoroselenolate, its O-methyl ester and methanephosphonate derivatives., 4 (8): [10.1016/S0960-894X(01)80676-4] |
Source(1):